Big Sioux Wealth Management’s Moleculin Biotech MBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.5K Buy
2,146
+1,140
+113% +$25.4K 0.01% 84
2026
Q2
$56.1K Buy
1,006
+241
+32% +$12.3K 0.03% 139
2026
Q1
$35K Buy
+765
New +$50.6K 0.02% 163

Other funds holding MBRX

Big Sioux Wealth Management's MBRX Position: Q3 2026 in Review

Big Sioux Wealth Management increased its Moleculin Biotech (MBRX) stake by 113% in Q3 2026, buying an estimated $25.4K and bringing the position to 2,146 shares worth $21.5K. The position accounts for 0.01% of the portfolio, ranked #84.

Big Sioux Wealth Management first reported a position in MBRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $56.1K in Q2 2026. 19 funds tracked by Wall St. Rank hold MBRX as of Q3 2026.

  • Big Sioux Wealth Management held 2,146 shares of Moleculin Biotech worth $21.5K as of Q3 2026.
  • Big Sioux Wealth Management bought 1,140 Moleculin Biotech shares in Q3 2026, an estimated $25.4K.
  • Moleculin Biotech made up 0.01% of Big Sioux Wealth Management's portfolio in Q3 2026, its #84 holding.
  • Big Sioux Wealth Management first reported a position in Moleculin Biotech in Q1 2026 and has held it in 3 quarters since.
  • Big Sioux Wealth Management's Moleculin Biotech position peaked at $56.1K in Q2 2026.
  • 19 funds tracked by Wall St. Rank held Moleculin Biotech as of Q3 2026.

Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.